169 related articles for article (PubMed ID: 32660355)
21. Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism.
Braadland PR; Grytli HH; Ramberg H; Katz B; Kellman R; Gauthier-Landry L; Fazli L; Krobert KA; Wang W; Levy FO; Bjartell A; Berge V; Rennie PS; Mellgren G; Mælandsmo GM; Svindland A; Barbier O; Taskén KA
Oncotarget; 2016 Jan; 7(2):1878-94. PubMed ID: 26646591
[TBL] [Abstract][Full Text] [Related]
22. Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.
Chouinard S; Pelletier G; Bélanger A; Barbier O
Endocr Res; 2004 Nov; 30(4):717-25. PubMed ID: 15666817
[TBL] [Abstract][Full Text] [Related]
23. Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.
Hu DG; Selth LA; Tarulli GA; Meech R; Wijayakumara D; Chanawong A; Russell R; Caldas C; Robinson JL; Carroll JS; Tilley WD; Mackenzie PI; Hickey TE
Cancer Res; 2016 Oct; 76(19):5881-5893. PubMed ID: 27496708
[TBL] [Abstract][Full Text] [Related]
24. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.
Vidal AC; Tucker C; Schildkraut JM; Richardson RM; McPhail M; Freedland SJ; Hoyo C; Grant DJ
BMC Cancer; 2013 Nov; 13():556. PubMed ID: 24267955
[TBL] [Abstract][Full Text] [Related]
25. Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer.
Park J; Chen L; Shade K; Lazarus P; Seigne J; Patterson S; Helal M; Pow-Sang J
J Urol; 2004 Jun; 171(6 Pt 1):2484-8. PubMed ID: 15126881
[TBL] [Abstract][Full Text] [Related]
26. Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate.
Karypidis AH; Olsson M; Andersson SO; Rane A; Ekström L
Pharmacogenomics J; 2008 Apr; 8(2):147-51. PubMed ID: 17387331
[TBL] [Abstract][Full Text] [Related]
27. Exemestane and Its Active Metabolite 17-Hydroexemestane Induce UDP-Glucuronosyltransferase (UGT) 2B17 Expression in Breast Cancer Cells.
Chanawong A; Mackenzie PI; McKinnon RA; Hu DG; Meech R
J Pharmacol Exp Ther; 2017 Jun; 361(3):482-491. PubMed ID: 28404691
[TBL] [Abstract][Full Text] [Related]
28. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.
Dubois SG; Beaulieu M; Lévesque E; Hum DW; Bélanger A
J Mol Biol; 1999 May; 289(1):29-39. PubMed ID: 10339403
[TBL] [Abstract][Full Text] [Related]
29. Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism.
Zhang H; Basit A; Busch D; Yabut K; Bhatt DK; Drozdzik M; Ostrowski M; Li A; Collins C; Oswald S; Prasad B
Biochem Pharmacol; 2018 Oct; 156():32-42. PubMed ID: 30086285
[TBL] [Abstract][Full Text] [Related]
30. The UGT2B17 gene deletion is not associated with prostate cancer risk.
Olsson M; Lindström S; Häggkvist B; Adami HO; Bälter K; Stattin P; Ask B; Rane A; Ekström L; Grönberg H
Prostate; 2008 Apr; 68(5):571-5. PubMed ID: 18247404
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor alpha, fos-related antigen-2, and c-Jun coordinately regulate human UDP glucuronosyltransferase 2B15 and 2B17 expression in response to 17beta-estradiol in MCF-7 cells.
Hu DG; Mackenzie PI
Mol Pharmacol; 2009 Aug; 76(2):425-39. PubMed ID: 19487245
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate.
Barbier O; Bélanger A
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):259-70. PubMed ID: 18471784
[TBL] [Abstract][Full Text] [Related]
33. Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus.
Ekström L; Johansson M; Rane A
Drug Metab Dispos; 2013 Feb; 41(2):291-5. PubMed ID: 23223495
[TBL] [Abstract][Full Text] [Related]
34. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
Turgeon D; Carrier JS; Lévesque E; Hum DW; Bélanger A
Endocrinology; 2001 Feb; 142(2):778-87. PubMed ID: 11159850
[TBL] [Abstract][Full Text] [Related]
35. Tissue specific differences in the regulation of the UDP glucuronosyltransferase 2B17 gene promoter.
Gregory PA; Hansen AJ; Mackenzie PI
Pharmacogenetics; 2000 Dec; 10(9):809-20. PubMed ID: 11191885
[TBL] [Abstract][Full Text] [Related]
36. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.
Swanson C; Mellström D; Lorentzon M; Vandenput L; Jakobsson J; Rane A; Karlsson M; Ljunggren O; Smith U; Eriksson AL; Bélanger A; Labrie F; Ohlsson C
J Clin Endocrinol Metab; 2007 Dec; 92(12):4878-82. PubMed ID: 17698910
[TBL] [Abstract][Full Text] [Related]
37. Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk.
Park JY; Tanner JP; Sellers TA; Huang Y; Stevens CK; Dossett N; Shankar RA; Zachariah B; Heysek R; Pow-Sang J
Urology; 2007 Aug; 70(2):374-9. PubMed ID: 17826523
[TBL] [Abstract][Full Text] [Related]
38. Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method.
Tchernof A; Lévesque E; Beaulieu M; Couture P; Després JP; Hum DW; Bélanger A
Clin Endocrinol (Oxf); 1999 May; 50(5):637-42. PubMed ID: 10468930
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity.
Gallagher CJ; Balliet RM; Sun D; Chen G; Lazarus P
Drug Metab Dispos; 2010 Dec; 38(12):2204-9. PubMed ID: 20810538
[TBL] [Abstract][Full Text] [Related]
40. Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.
Ménard V; Eap O; Harvey M; Guillemette C; Lévesque E
Hum Mutat; 2009 Sep; 30(9):1310-9. PubMed ID: 19572376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
